2.0
27. Juli 2013
Ehemaliger Mitarbeiter, mehr als 1 Jahr
East Hanover, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Part of Novartis group, Financial muscle for deal making, QbD awareness, interesting projects
Kontras
Middle / mid-senior management is complacent to paranoid, nothing much gets done, top heavy, no accountability culture. They had a layoff in 2012-13, but even that was a political mess. It's like the more things change, the more they stay the same.